How is the GlycoMimetics Inc today?

The GlycoMimetics Inc today is trading in the down by -5.92% at 15.90.

How has GlycoMimetics Inc performed historically?

The GlycoMimetics Inc is currently trading down -5.92% on an intraday basis in the past week the index rose 8.76%. The index has been down -34.84% in the past quarter and fell -45.55% in the past year. You can view this in the overview section.

What is GlycoMimetics Inc Annual Net Profit?

GlycoMimetics Inc Annual Net Profit fell 2.66% in the last year to $37.88 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is GlycoMimetics Inc Price to Earning Ratio?

GlycoMimetics Inc Price to Earning Ratio is -34.8, which is negative.

What is GlycoMimetics Inc Stock Price?

GlycoMimetics Inc Stock Price fell 45.55% and underperformed its sector by 80.42% in the past year.

What is GlycoMimetics Inc Quarterly Net profit?

GlycoMimetics Inc Quarterly Net profit rose 78.17% YoY to $2.34 M. Its sector's average net profit growth YoY for the quarter was -235.94%.

What is GlycoMimetics Inc Debt to Equity Ratio?

GlycoMimetics Inc Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is GlycoMimetics Inc Return on Equity(ROE)?

GlycoMimetics Inc Return on Equity(ROE) for the last financial year was -173.25%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is GlycoMimetics Inc Mutual Fund Holding?

GlycoMimetics Inc Mutual Fund Holding decreased by 7.49% in the last quarter to 1.32.

What is GlycoMimetics Inc Promoter Share Holding?

GlycoMimetics Inc Promoter Share Holding stayed the same in the most recent quarter at 2.67%.

What is GlycoMimetics Inc Institutional Holding?

GlycoMimetics Inc Institutional Holding increased by 0.02% in the last quarter to 47.06.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
GLYCOMIMETICS INC

GlycoMimetics Inc XNAS: GLYC

GlycoMimetics Inc Live Share Price Today, Share Analysis and Chart

Name: GlycoMimetics Inc: Is Infosys Ltd. worth buying?
Item: GlycoMimetics Inc
Rating: 0.82216675
Author: Trendlyne DVM scores

about

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimeti...

15.90 -1.00 (-5.92%)

74.76% Fall from 52W High

54,356

XNAS Volume

XNAS 27 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.2 / 100

Technically Bearish

32.7 / 100

1Yr Price target downside is -94%

1 analysts

GlycoMimetics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

GlycoMimetics Inc Live Share Price Today, Share Analysis and Chart

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimeti...

74.76% Fall from 52W High

SWOT Analysis

GlycoMimetics Inc Live Price Chart

GlycoMimetics Inc FAQ

How is GlycoMimetics Inc today?

GlycoMimetics Inc today is trading in the red, and is down by -5.92% at 15.90.

How has GlycoMimetics Inc performed historically?

GlycoMimetics Inc is currently trading down -5.92% on an intraday basis. In the past week the stock rose 8.76%. stock has been down -34.84% in the past quarter and fell -45.55% in the past year. You can view this in the overview section.